ADHD and Hyperkinetic Disorder

This pocketbook serves as a concise and practical guide to the management of ADHD for child and adolescent psychiatrists and child psychologists, paediatricians, trainees, psychiatric specialist nurses, interested general practitioners, and other mental health professionals. The pocketbook provides a user-friendly introduction to the clinical understanding, evaluation, and treatment of ADHD. This edition has been updated to include new DSM-5 diagnostic criteria (May 2013) and to reflect more published studies on ADHD in the adult population, along with new data on the CNS stimulant drug LDX (Lisdexamfetamine Dimesylate).

Tobias Banaschewski, Medical Director, Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Mannheim, Germany,Alessandro Zuddas,Professor of Child NeuroPsychiatry, Department of Biomedical Sciences, University of Cagliari, Cagliari, Sardinia,Italy,Philip Asherson, Professor in Molecular Psychiatry and Honorary Consultant Psychiatrist, MRC Social, Genetic, and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London, UK,Jan Buitelaar,Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands,David Coghill,Senior Lecturer in Child and Adolescent Psychiatry, Division of Neuroscience, Medical Research Institute, Ninewells Hospital and Medical School, Dundee, UK,Marina Danckaerts,Department of Child and Adolescent Psychiatry, University Hospitals Leuven, Leuven, Belgium,Manfred Dopfner,Departme

Tobias Banaschewski, MD, PhD, is Professor of Child and Adolescent Psychiatry at the Medical Faculty Mannheim of the University of Heidelberg and Medical Director of the Department of Child and Adolescent Psychiatry of the Central Institute of Mental Health in Mannheim, Germany. Dr. Banaschewski studied psychology and medicine at the University of Marburg in Germany. He worked as Clinical Assistant in Adult Psychiatry in Marburg and as Clinical and Research Assistant in Child & Adolescent Psychiatry at the University of Gottingen, Germany.

Alessandro Zuddas is Professor of Child NeuroPsychiatry at the Department of Biomedical Sciences, University of Cagliari, Cagliari, Sardinia, Italy.

Philip Asherson, MB,BS, MRCPsych, PhD is Professor of Molecular Psychiatry at the MRC Social, Genetic and Developmental Psychiatry centre at the Institute of Psychiatry, King's College London, and consultant psychiatrist at the Maudsley Hospital. He earned his medical degree from The Royal London Hospital and his doctoral degree from the University of Wales. He was an MRC Clinical Research Fellow in the Department of Psychological Medicine & Institute of Medical Genetics at the University Of Wales College Of Medicine in Cardiff, where he worked on molecular genetic studies of schizophrenia. His current work focuses on clinical, quantitative genetic and molecular genetic studies of ADHD across the lifespan. He has contributed to the development of mental health services for adults with ADHD in the UK.

Jan Buitelaar (MD, PhD) is child and adolescent psychiatrist, and professor of Psychiatry and Child and Adolescent Psychiatry, and head of the Department of Psychiatry of RUNMC, and of the Karakter Child and Adolescent Psychiatry University Centre. He has been involved in numerous medication trials in children and adolescents with ADHD, Conduct Disorder and Autism Spectrum Disorder. He is Editor-in-chief of European Child and Adolescent Psychiatry. He is further active in genetic, brain imaging and cognitive studies, and has published over 240 peer-reviewed papers.

David Coghill (MB ChB MRCPsych) is child and adolescent psychiatrist, and senior lecturer in Child and Adolescent Psychiatry, at the University of Dundee and Honorary Consultant Child and Adolescent Psychiatrist in the Tayside Child and Adolescent Mental Health Service. He has been involved in several trials in children and adolescents with ADHD and Conduct Disorder and is currently the global lead investigator for two large multinational clinical trials. He is also active in genetic, neuropsychological, neuropsychopharmacological and quality of life research.

Marina Danckaerts (MD, PhD) is a Clinical Professor at the University Hospital Leuven and the Katholieke Universiteit Leuven and is also Head of the Department of Child and Adolescent Psychiatry. She is a national Principle Inv